Spots Global Cancer Trial Database for Assessment of Safety and Efficacy of Vilaprisan in Subjects With Uterine Fibroids
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Assessment of Safety and Efficacy of Vilaprisan in Subjects With Uterine Fibroids
Official Title: A Randomized, Parallel-group, Double-blind Placebo-controlled, Multicenter Study to Assess the Efficacy and Safety of Vilaprisan in Subjects With Uterine Fibroids
Study ID: NCT03699176
Conditions
Study Description
Brief Summary: The primary objective of this study is to show superiority of vilaprisan in the treatment of heavy menstrual bleeding (HMB) in subjects with uterine fibroids compared to placebo.The secondary objectives of this study are to additionally evaluate the efficacy and safety of vilaprisan in subjects with uterine fibroids.
Detailed Description:
Keywords
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: FEMALE
Healthy Volunteers: No
Locations
Funabashi Municipal Medical Center, Funabashi, Chiba, Japan
Matsudo City General Hospital, Matsudo, Chiba, Japan
Ena Odori Clinic, Sapporo, Hokkaido, Japan
Tokeidai Memorial Clinic, Sapporo, Hokkaido, Japan
Asahi clinic, Takamatsu, Kagawa, Japan
Kagawa Prefectural Central Hospital, Takamatsu, Kagawa, Japan
Unoki Clinic, Kagoshima, , Japan
Japanese Red Cross Kumamoto Hospital, Kumamoto, , Japan
Contact Details
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
